Home » Topics » BioWorld Science

BioWorld Science
RSS

CB2 receptor PET radiotracer [11C]MDTC evaluated in first-in-human study

July 11, 2019

Myovant Sciences presents phase II data on MVT-602 in premenopausal women

July 11, 2019

Roche describes new hepatitis B virus cccDNA formation inhibitors

July 11, 2019

New catalytic system allows selective cancer cell targeting

July 11, 2019

Chengdu Huajian Future Technology patents IDO-1 inhibitors

July 11, 2019

New PD-1/PD-L1 interaction inhibitors described by Yangtze River, Shanghai Haiyan

July 11, 2019

Chiesi discovers Rho kinase inhibitors

July 11, 2019

Guangdong Newopp Biopharmaceuticals presents new arginase inhibitors

July 11, 2019

Researchers develop CRISPR/Cas9 hemophilia A murine model

July 11, 2019

First patient dosed in phase II study of KD-025 in cutaneous systemic sclerosis

July 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...